Oncology Central

Circulating free DNA in plasma or serum as biomarkers of carcinogenesis in colon cancer


Colorectal cancer: prevalence & current trends in diagnosis

Colorectal cancer (CRC) accounts for approximately 9% of total worldwide cancer causes, it is the fourth most common cancer among men and the third among women [1,2]. In the UK, CRC represents the second most common cause of death due to cancer with more than 100 cases diagnosed every day [3]. To date, the main prognostic predictor as well as the treatment in patients with CRC are mainly based upon clinical and pathologic tumor staging [4].

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.